ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/10/01 | 4,485 | 4,645 | 4,390 | 4,615 | +140 | +3.1% | 246,500 |
2018/09/28 | 4,450 | 4,480 | 4,205 | 4,475 | +95 | +2.2% | 376,000 |
2018/09/27 | 4,610 | 4,880 | 4,305 | 4,380 | -100 | -2.2% | 984,400 |
2018/09/26 | 4,480 | 4,480 | 4,480 | 4,480 | +700 | +18.5% | 28,700 |
2018/09/25 | 3,865 | 3,865 | 3,760 | 3,780 | -50 | -1.3% | 82,200 |
2018/09/21 | 3,830 | 3,895 | 3,780 | 3,830 | +60 | +1.6% | 135,800 |
2018/09/20 | 3,780 | 3,830 | 3,710 | 3,770 | +40 | +1.1% | 105,300 |
2018/09/19 | 3,660 | 3,815 | 3,630 | 3,730 | +70 | +1.9% | 147,900 |
2018/09/18 | 3,655 | 3,685 | 3,555 | 3,660 | -25 | -0.7% | 118,500 |
2018/09/14 | 3,540 | 3,705 | 3,520 | 3,685 | +190 | +5.4% | 173,100 |
2018/09/13 | 3,525 | 3,615 | 3,425 | 3,495 | -70 | -2% | 126,900 |
2018/09/12 | 3,595 | 3,625 | 3,500 | 3,565 | -55 | -1.5% | 106,000 |
2018/09/11 | 3,720 | 3,740 | 3,615 | 3,620 | -55 | -1.5% | 80,600 |
2018/09/10 | 3,600 | 3,710 | 3,595 | 3,675 | +55 | +1.5% | 76,600 |
2018/09/07 | 3,625 | 3,635 | 3,510 | 3,620 | -5 | -0.1% | 121,000 |
2018/09/06 | 3,640 | 3,685 | 3,510 | 3,625 | -85 | -2.3% | 192,200 |
2018/09/05 | 3,875 | 3,925 | 3,660 | 3,710 | -205 | -5.2% | 220,900 |
2018/09/04 | 3,795 | 3,960 | 3,760 | 3,915 | +85 | +2.2% | 164,200 |
2018/09/03 | 3,970 | 4,030 | 3,805 | 3,830 | -140 | -3.5% | 171,800 |
2018/08/31 | 3,820 | 3,990 | 3,785 | 3,970 | +100 | +2.6% | 209,500 |
2018/08/30 | 4,025 | 4,100 | 3,855 | 3,870 | -85 | -2.1% | 315,900 |
2018/08/29 | 3,830 | 3,970 | 3,795 | 3,955 | +115 | +3% | 169,800 |
2018/08/28 | 3,840 | 3,945 | 3,775 | 3,840 | +55 | +1.5% | 245,400 |
2018/08/27 | 3,775 | 3,835 | 3,750 | 3,785 | +45 | +1.2% | 153,900 |
2018/08/24 | 3,700 | 3,845 | 3,610 | 3,740 | ±0 | ±0% | 282,000 |
2018/08/23 | 3,800 | 3,875 | 3,665 | 3,740 | +30 | +0.8% | 405,900 |
2018/08/22 | 3,350 | 3,735 | 3,340 | 3,710 | +325 | +9.6% | 392,300 |
2018/08/21 | 3,305 | 3,530 | 3,265 | 3,385 | +40 | +1.2% | 245,000 |
2018/08/20 | 3,365 | 3,470 | 3,205 | 3,345 | +160 | +5% | 332,600 |
2018/08/17 | 3,000 | 3,190 | 2,976 | 3,185 | +260 | +8.9% | 216,900 |
2018/08/16 | 2,863 | 2,989 | 2,803 | 2,925 | -38 | -1.3% | 256,500 |
2018/08/15 | 3,200 | 3,225 | 2,931 | 2,963 | -307 | -9.4% | 399,000 |
2018/08/14 | 3,115 | 3,325 | 3,115 | 3,270 | +175 | +5.7% | 184,800 |
2018/08/13 | 3,210 | 3,215 | 3,060 | 3,095 | -70 | -2.2% | 147,600 |
2018/08/10 | 3,205 | 3,250 | 3,160 | 3,165 | -15 | -0.5% | 67,100 |
2018/08/09 | 3,220 | 3,280 | 3,135 | 3,180 | -75 | -2.3% | 68,300 |
2018/08/08 | 3,115 | 3,310 | 3,110 | 3,255 | +125 | +4% | 107,700 |
2018/08/07 | 3,030 | 3,180 | 3,030 | 3,130 | +30 | +1% | 129,200 |
2018/08/06 | 3,230 | 3,250 | 3,080 | 3,100 | -200 | -6.1% | 222,900 |
2018/08/03 | 3,435 | 3,465 | 3,295 | 3,300 | -135 | -3.9% | 105,300 |
2018/08/02 | 3,280 | 3,450 | 3,280 | 3,435 | +105 | +3.2% | 87,600 |
2018/08/01 | 3,405 | 3,445 | 3,325 | 3,330 | -75 | -2.2% | 87,600 |
2018/07/31 | 3,340 | 3,430 | 3,260 | 3,405 | +15 | +0.4% | 153,600 |
2018/07/30 | 3,555 | 3,555 | 3,385 | 3,390 | -165 | -4.6% | 179,800 |
2018/07/27 | 3,550 | 3,585 | 3,510 | 3,555 | +30 | +0.9% | 66,300 |
2018/07/26 | 3,615 | 3,630 | 3,520 | 3,525 | -20 | -0.6% | 96,000 |
2018/07/25 | 3,585 | 3,590 | 3,540 | 3,545 | -10 | -0.3% | 57,900 |
2018/07/24 | 3,620 | 3,635 | 3,530 | 3,555 | -15 | -0.4% | 104,900 |
2018/07/23 | 3,655 | 3,715 | 3,565 | 3,570 | -175 | -4.7% | 166,900 |
2018/07/20 | 3,810 | 3,870 | 3,720 | 3,745 | -90 | -2.3% | 96,400 |
1601~
1650
件表示中 / 3687件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 223,700円 | +21.7% | +999.9% | 0.00% | 9.32倍 | 3.08倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
ゼリア新薬 | 232,500円 | +14.2% | +41.0% | 1.98% | 11.39倍 | 1.16倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 311,000円 | +3.0% | +27.5% | 2.57% | 19.69倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 149,500円 | +8.8% | +99.9% | 3.48% | 9.54倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 225,100円 | +0.4% | -8.4% | 2.35% | 28.90倍 | 1.63倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム